NEXTGEN: Nurturing next generation of diverse research leaders by providing mentored research experiences

NEXTGEN:通过提供指导性研究经验来培养下一代多元化研究领导者

基本信息

项目摘要

ABSTRACT The goal of this supplement is to enhance mentorship skills in working effectively with talented physician- scientists from a variety of backgrounds, support one additional T32 trainee who is a woman of minority underrepresented in medicine, and support five mentored research experiences in age-related conditions. Given the growing number of older adults globally, the health-related issues of older adults will dominate the health care landscape. Physician-scientists are well poised to conduct translational research relevant to the older population, particularly in understanding health disparities, as they can appreciate the clinical implications of systemic health and social inequities and have a unique ability to identify areas of research likely to have a substantial impact on clinical care. University of Michigan (UM) is uniquely positioned to train promising physician-scientists from diverse backgrounds in age-related research as UM has made a priority to recruit and train physician-scientists underrepresented in academia. UM has robust programs in geroscience/biology of aging, geriatrics, clinical medicine and health policy research, as well as innovative offices advancing anti-racism and anti-discrimination efforts. The UM Office of Diversity, Equity, and Inclusion (ODEI) supports initiatives throughout the UM focused on the recruitment and retention of diverse faculty, staff, and students. Within Michigan Medicine, the Office for Health Equity and Inclusion (OHEI) develops mechanisms for inclusion, diversity and cultural sensitivity among faculty, students and staff. In order to achieve our program goals, we have included five mentored research experiences that will enhance minority recruitment and representation, including projects of three minority researchers and a focus on health disparities. Their mentors represent the spectrum of translational medical research from preclinical research, through to research in healthy and diseased human subjects (i.e., translational), to public policy and population health. Dr. Mody is a clinical interventionalist who has active collaborations with investigators who conduct basic genomic research to scientists in healthcare research policy. Our training program includes mentors for each of the trainees and their mentored research projects. In addition to the individual expertise of the faculty, our program also will leverage several successful programs at UM including: The University of Michigan Older Americans Independence Center, the Michigan Institute for Clinical and Health Research, Biology of Aging, Institute for Healthcare Policy and Research, Michigan Biology of Cardiovascular Aging and Institute for Social Research. We expect that this supplement will advance and support a cadre of outstandingly trained young physician-scientists who will pursue cutting-edge translational research in age-related conditions, with particular emphasis in health disparities and access to care among minority populations, and themselves become mentors and leaders in the field.
抽象的 这种补充的目的是在与才华横溢的医生有效合作中提高指导能力 - 来自各种背景的科学家,支持另外一名T32学员,她是少数族裔的女性 在医学方面的代表性不足,并在与年龄有关的情况下支持五项指导的研究经验。 鉴于全球老年人人数越来越多,老年人与健康相关的问题将主导 医疗保健领域。医师科学家们有很好的准备进行与 老年人,特别是在理解健康差异方面,因为他们可以欣赏临床 系统健康和社会不平等的含义,并具有识别研究领域的独特能力 可能会对临床护理产生重大影响。密歇根大学(UM)的独特位置可以训练 来自与年龄有关的研究的有前途的医师科学家,因为UM已优先考虑 在学术界的招聘和培训医师科学家人数不足。 UM有强大的程序 衰老,老年医学,临床医学和卫生政策研究以及创新 办公室推进了反种族主义和反歧视努力。 UM多样性,公平和 包容(ODEI)支持整个UM的倡议,重点是招募和保留多样化 教职员工和学生。在密歇根州医学中,卫生公平与包容局(OHEI) 开发了教师,学生和教职员工中包容,多样性和文化敏感性的机制。在 为了实现我们的计划目标,我们提供了五种有指导的研究经验,可以增强 少数族裔招聘和代表,包括三名少数族裔研究人员的项目,重点是 健康差异。他们的导师代表了临床前转化医学研究的范围 研究,通过研究健康和患病的人类受试者(即翻译)的研究,到公共政策和 人口健康。 Mody博士是一位临床介入主义者,他与调查人员有积极的合作 对医疗保健研究政策的科学家进行基本基因组研究。我们的培训计划包括 每个受训者及其指导的研究项目的指导者。除了个人专业知识 教师,我们的计划还将利用UM的几个成功计划,包括: 密歇根州临床与健康研究所密歇根州年龄较大的美国人独立中心, 衰老的生物学,医疗保健政策与研究研究所,密歇根州心血管衰老的生物学 社会研究研究所。我们希望这种补充剂将推进并支持一群遥不可及的干部 受过训练的年轻医师科学家将在与年龄有关的尖端翻译研究 条件,特别强调健康差异和少数民族之间的护理,以及 自己成为该领域的导师和领导者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel Robert Goldstein其他文献

Daniel Robert Goldstein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel Robert Goldstein', 18)}}的其他基金

Role of mitophagy in age-related respiratory and vascular diseases
线粒体自噬在年龄相关呼吸和血管疾病中的作用
  • 批准号:
    10322449
  • 财政年份:
    2021
  • 资助金额:
    $ 22.71万
  • 项目类别:
Role of mitophagy in age-related respiratory and vascular diseases
线粒体自噬在年龄相关呼吸和血管疾病中的作用
  • 批准号:
    10541147
  • 财政年份:
    2021
  • 资助金额:
    $ 22.71万
  • 项目类别:
Physician Scientist Training in Age-Related Diseases
年龄相关疾病的医师科学家培训
  • 批准号:
    10627823
  • 财政年份:
    2020
  • 资助金额:
    $ 22.71万
  • 项目类别:
Physician Scientist Training in Age-Related Diseases
年龄相关疾病的医师科学家培训
  • 批准号:
    10425464
  • 财政年份:
    2020
  • 资助金额:
    $ 22.71万
  • 项目类别:
Novel mechanisms of age-enhanced vasculopathy after heart transplantation
心脏移植后年龄加重血管病变的新机制
  • 批准号:
    10088381
  • 财政年份:
    2018
  • 资助金额:
    $ 22.71万
  • 项目类别:
Novel mechanisms of age-enhanced vasculopathy after heart transplantation
心脏移植后年龄加重血管病变的新机制
  • 批准号:
    10329932
  • 财政年份:
    2018
  • 资助金额:
    $ 22.71万
  • 项目类别:
Novel Inflammatory Pathway of Aged-Enhanced Atherosclerosis
老年性动脉粥样硬化的新炎症途径
  • 批准号:
    9266471
  • 财政年份:
    2016
  • 资助金额:
    $ 22.71万
  • 项目类别:
Academic leadership in the Biology of Aging and Cardiovascular Diseases
衰老和心血管疾病生物学领域的学术领导地位
  • 批准号:
    8869159
  • 财政年份:
    2015
  • 资助金额:
    $ 22.71万
  • 项目类别:
Hyaluronan as an innate ligand that induces inflammation after transplantation
透明质酸作为先天配体,在移植后诱导炎症
  • 批准号:
    8242964
  • 财政年份:
    2012
  • 资助金额:
    $ 22.71万
  • 项目类别:
Hyaluronan as an innate ligand that induces inflammation after transplantation
透明质酸作为先天配体,在移植后诱导炎症
  • 批准号:
    8516457
  • 财政年份:
    2012
  • 资助金额:
    $ 22.71万
  • 项目类别:

相似国自然基金

环境司法专门化的绿色治理效应与影响机制研究——来自非上市企业的经验证据
  • 批准号:
    72302131
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
金融科技对银行中介与货币政策传导的影响研究——基于存款市场的理论、经验证据和机制分析
  • 批准号:
    72303208
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
经验刻印和演化驱动的科研人员重复性产学互动倾向的动态时变模式:基于学企跨界人员流动的研究
  • 批准号:
    72374084
  • 批准年份:
    2023
  • 资助金额:
    41 万元
  • 项目类别:
    面上项目
资源产业依赖对儿童营养健康的影响研究:理论与中国经验
  • 批准号:
    72304173
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Arlene George F32
阿琳·乔治 F32
  • 批准号:
    10722238
  • 财政年份:
    2024
  • 资助金额:
    $ 22.71万
  • 项目类别:
Identifying Predictors of Condom Use
确定安全套使用的预测因素
  • 批准号:
    10821861
  • 财政年份:
    2024
  • 资助金额:
    $ 22.71万
  • 项目类别:
Core B: Clinical Trials Core
核心 B:临床试验核心
  • 批准号:
    10554476
  • 财政年份:
    2023
  • 资助金额:
    $ 22.71万
  • 项目类别:
JAX Diversity Action Plan (DAP) Post-Baccalaureate Program in Genomics (gDAP)
JAX 多样性行动计划 (DAP) 基因组学学士后计划 (gDAP)
  • 批准号:
    10555588
  • 财政年份:
    2023
  • 资助金额:
    $ 22.71万
  • 项目类别:
Northern California Acute Care Research Consortium (NORCARES)
北加州急症护理研究联盟 (NORCARES)
  • 批准号:
    10552463
  • 财政年份:
    2023
  • 资助金额:
    $ 22.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了